SEC Form 4 · accession 0001140361-15-005042
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel K Spiegelman
Officer — EVP, Chief Financial Officer
Period of report
Mar 18, 2013
Accepted (ET)
Feb 10, 2015 · 12:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 18, 2013 | A | 7 | $61.4829 | A | 68,683 | D | |
| Common Stock | Mar 18, 2013 | A | 7 | $61.3814 | A | 68,690 | D | |
| Common Stock | Mar 20, 2013 | A | 5 | $61.988 | A | 68,695 | D | |
| Common Stock | Mar 20, 2013 | A | 4 | $61.4325 | A | 68,699 | D | |
| Common Stock | Jun 19, 2013 | A | 9 | $58.5678 | A | 68,708 | D | |
| Common Stock | Jun 19, 2013 | A | 9 | $58.8478 | A | 68,717 | D | |
| Common Stock | Sep 10, 2013 | A | 8 | $70.0583 | A | 68,725 | D | |
| Common Stock | Sep 10, 2013 | A | 7 | $70.3029 | A | 68,732 | D | |
| Common Stock | Oct 4, 2013 | A | 5 | $74.074 | A | 68,737 | D | |
| Common Stock | Oct 7, 2013 | A | 6 | $74.8383 | A | 68,743 | D | |
| Common Stock | Oct 30, 2013 | A | 4 | $66.475 | A | 68,747 | D | |
| Common Stock | Oct 30, 2013 | A | 5 | $65.75 | A | 68,752 | D | |
| Common Stock | Nov 20, 2013 | A | 8 | $65.8863 | A | 68,760 | D | |
| Common Stock | Mar 5, 2014 | S | 12 | $82.9258 | D | 68,748 | D | |
| Common Stock | May 2, 2014 | S | 3 | $58.0233 | D | 68,745 | D | |
| Common Stock | May 2, 2014 | S | 8 | $58.78 | D | 68,737 | D | |
| Common Stock | Aug 6, 2014 | A | 7 | $62.1671 | A | 68,744 | D | |
| Common Stock | Aug 6, 2014 | A | 7 | $62.1771 | A | 68,751 | D | |
| Common Stock | Sep 3, 2014 | S | 9 | $69.8289 | D | 68,742 | D | |
| Common Stock | Sep 3, 2014 | S | 9 | $69.7011 | D | 68,733 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Inadvertent transaction not directed by the reporting person through a broker-administered investment pool.
- F2Some of the transactions executed as reported herein resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"). The Reporting Person has made arrangements with the Issuer to disgorge short swing profits realized to the Issuer, and upon settlement, the Reporting Person will have discharged in full any obligation under Section 16(b) with respect to the reported transactions.